Blue Earth Diagnostics Limited

Royaume‑Uni

Retour au propriétaire

1-34 de 34 pour Blue Earth Diagnostics Limited Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 19
        Marque 15
Juridiction
        États-Unis 16
        International 10
        Europe 5
        Canada 3
Date
2024 3
2023 7
2022 1
2021 7
2020 4
Voir plus
Classe IPC
A61K 51/04 - Composés organiques 17
A61B 6/03 - Tomographie informatisée 4
A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations 3
A61K 101/02 - Halogènes 3
C07B 59/00 - Introduction d'isotopes d'éléments dans les composés organiques 3
Voir plus
Classe NICE
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 15
05 - Produits pharmaceutiques, vétérinaires et hygièniques 15
42 - Services scientifiques, technologiques et industriels, recherche et conception 8
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 5
10 - Appareils et instruments médicaux 1
Statut
En Instance 6
Enregistré / En vigueur 28

1.

RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP)

      
Numéro d'application 18577580
Statut En instance
Date de dépôt 2022-07-08
Date de la première publication 2024-12-05
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Rahman, Sabitur
  • Bejot, Romain
  • Liang, Guyan
  • Haji, Abdul Karim
  • Barnes, Colin

Abrégé

The present invention relates to a ligand-SIFA conjugate, comprising, within in a single molecule two separate moieties: (a) one or more ligands which are capable of binding to Fibroblast Activation Protein (FAP), and (b) a silicon-fluoride acceptor (SI FA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom.

Classes IPC  ?

2.

METHODS OF PREPARATION OF 18F LABELLED SILYL-FLUORIDE COMPOUNDS

      
Numéro d'application 18694567
Statut En instance
Date de dépôt 2022-09-26
Date de la première publication 2024-11-21
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s)
  • Bejot, Romain
  • Osborn, Nigel
  • Wurzer, Alexander Josef

Abrégé

The present invention relates to methods of preparation of a solution comprising an 18F labelled silyl-fluoride compound. Compounds and compositions obtained by the methods of the invention may be useful as positron emission tomography (PET) imaging agents. Compounds and compositions obtained by the methods of the invention may be useful in the diagnosis or imaging of angiogenesis or cancer.

Classes IPC  ?

  • A61K 51/04 - Composés organiques
  • C07B 59/00 - Introduction d'isotopes d'éléments dans les composés organiques

3.

PHARMACEUTICAL FORMULATIONS

      
Numéro d'application 18435245
Statut En instance
Date de dépôt 2024-02-07
Date de la première publication 2024-08-22
Propriétaire
  • Blue Earth Diagnostics Limited (Royaume‑Uni)
  • Siemens Medical Solutions USA, Inc. (USA)
Inventeur(s)
  • Bejot, Romain
  • Haka, Michael
  • Anzellotti, Atilio

Abrégé

The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a ph of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/ml ethanol; and 5-10 mg/ml sodium chloride.

Classes IPC  ?

  • A61K 51/04 - Composés organiques
  • A61K 47/02 - Composés inorganiques
  • A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
  • A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides

4.

SYNTHESIS OF FLUOROSILYL COMPOUNDS

      
Numéro d'application GB2023051326
Numéro de publication 2023/223050
Statut Délivré - en vigueur
Date de dépôt 2023-05-19
Date de publication 2023-11-23
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Ford, Rhonan Lee
  • Thomas, Alexander James Floyd
  • Rahman, Sabitur

Abrégé

The disclosures herein relate to methods of synthesising a compound of formula (1): (1) wherein PG, R2 and R3 are as defined herein, and the use of said methods in the manufacture of conjugates that bind to PSMA.

Classes IPC  ?

  • C07F 7/12 - Halogénures organo-siliciques
  • A61K 51/04 - Composés organiques
  • C07B 59/00 - Introduction d'isotopes d'éléments dans les composés organiques
  • C07F 5/00 - Composés contenant des éléments des groupes 3 ou 13 du tableau périodique

5.

IMAGING OF MYELOMA BONE LESIONS

      
Numéro d'application 18151204
Statut En instance
Date de dépôt 2023-01-06
Date de la première publication 2023-07-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s) Teoh, Eugene

Abrégé

The present disclosure relates to methods of administering [18F]-FACBC for imaging, diagnosing, and/or monitoring of myeloma bone lesions.

Classes IPC  ?

  • A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations
  • A61B 6/03 - Tomographie informatisée
  • A61K 51/04 - Composés organiques

6.

IMAGING OF MYELOMA BONE LESIONS

      
Numéro d'application GB2023050028
Numéro de publication 2023/131800
Statut Délivré - en vigueur
Date de dépôt 2023-01-09
Date de publication 2023-07-13
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s) Teoh, Eugene

Abrégé

The present disclosure relates to methods of administering [18F]-FACBC for imaging, diagnosing, and/or monitoring of myeloma bone lesions.

Classes IPC  ?

7.

IMAGING OF BRAIN LESIONS

      
Numéro d'application 17508007
Statut En instance
Date de dépôt 2021-10-22
Date de la première publication 2023-04-27
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s) Teoh, Eugene

Abrégé

The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing, and monitoring of brain lesions.

Classes IPC  ?

  • A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations
  • A61K 51/04 - Composés organiques
  • A61B 6/03 - Tomographie informatisée

8.

IMAGING OF BRAIN LESIONS

      
Numéro d'application GB2022052666
Numéro de publication 2023/067337
Statut Délivré - en vigueur
Date de dépôt 2022-10-19
Date de publication 2023-04-27
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Teoh, Eugene
  • Miller, Matthew
  • Holmes, Robin

Abrégé

The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing, and monitoring of brain lesions.

Classes IPC  ?

9.

METHODS OF PREPARATION OF 18F LABELLED SILYL-FLUORIDE COMPOUNDS

      
Numéro d'application GB2022052432
Numéro de publication 2023/047138
Statut Délivré - en vigueur
Date de dépôt 2022-09-26
Date de publication 2023-03-30
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Bejot, Romain
  • Osborn, Nigel
  • Wurzer, Alexander Josef

Abrégé

The present invention relates to methods of preparation of a solution comprising an 18F labelled silyl-fluoride compound. Compounds and compositions obtained by the methods of the invention may be useful as positron emission tomography (PET) imaging agents. Compounds and compositions obtained by the methods of the invention may be useful in the diagnosis or imaging of angiogenesis or cancer.

Classes IPC  ?

10.

RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP)

      
Numéro d'application US2022073544
Numéro de publication 2023/283627
Statut Délivré - en vigueur
Date de dépôt 2022-07-08
Date de publication 2023-01-12
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s)
  • Rahman, Sabitur
  • Bejot, Romain
  • Liang, Guyan
  • Haji, Abdul, Karim
  • Barnes, Colin

Abrégé

The present invention relates to a ligand-SIFA conjugate, comprising, within in a single molecule two separate moieties: (a) one or more ligands which are capable of binding to Fibroblast Activation Protein (FAP), and (b) a silicon-fiuoride acceptor (SI FA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom.

Classes IPC  ?

11.

BLUE EARTH

      
Numéro d'application 1648211
Statut Enregistrée
Date de dépôt 2021-12-02
Date d'enregistrement 2021-12-02
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive elements for scientific purposes; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging (non-medical). PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic and therapeutic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging (for medical use); chemicals for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy. Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services. Medical services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services.

12.

Imaging of metastatic or recurrent cancer

      
Numéro d'application 17350104
Numéro de brevet 11980674
Statut Délivré - en vigueur
Date de dépôt 2021-06-17
Date de la première publication 2021-12-23
Date d'octroi 2024-05-14
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s)
  • Teoh, Eugene
  • Miller, Matthew
  • Gardiner, Peter

Abrégé

18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.

Classes IPC  ?

  • A61K 51/04 - Composés organiques
  • A61B 6/00 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations
  • A61B 6/03 - Tomographie informatisée
  • A61B 6/50 - Appareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations spécialement adaptés à des parties du corps spécifiquesAppareils ou dispositifs pour le diagnostic par radiationsAppareils ou dispositifs pour le diagnostic par radiations combinés avec un équipement de thérapie par radiations spécialement adaptés à des applications cliniques spécifiques

13.

BLUE EARTH

      
Numéro d'application 217004900
Statut Enregistrée
Date de dépôt 2021-12-02
Date d'enregistrement 2024-08-16
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Chemicals for use in molecular imaging; diagnostic chemical agents namely, Positron Emission Tomography (PET) imaging tracers for diagnosing cancer; Positron Emission Tomography (PET) imaging tracers; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive isotopes for scientific research use for the diagnosis of cancer; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; non-medical diagnostic scanning agents for in-vivo use; non-medical chemicals for use in molecular imaging. (2) Positron Emission Tomography (PET) imaging tracers for detecting cancer; Positron Emission Tomography (PET) imaging tracers for ingestion or injection into humans and animals for detecting cancer; diagnostic preparations for medical purposes namely, radiopharmaceuticals for use in detecting cancer; therapeutic preparations for medical purposes namely for treating cancer; reagents for use in Positron Emission Tomography (PET) imaging ;diagnostic scanning agents for medical use, namely for detecting cancer; preparations for use in molecular imaging (for medical use); pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy. (1) Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; computer-aided diagnostic imaging services for scientific purposes; development of image processing software for scientific imaging; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services. (2) Medical services, namely medical testing services, medical care and analysis services relating to patient treatment, medical clinic services, medical diagnostic services, and medical examination services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services.

14.

BLUE EARTH

      
Numéro de série 79334964
Statut Enregistrée
Date de dépôt 2021-12-02
Date d'enregistrement 2023-09-12
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers for laboratory or research use; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive elements for scientific purposes; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; non-medical diagnostic scanning agents for in-vivo use; non-medical chemicals for use in molecular imaging PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic and therapeutic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging for medical use; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services Medical services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services

15.

Pharmaceutical formulations

      
Numéro d'application 17226848
Numéro de brevet 12036290
Statut Délivré - en vigueur
Date de dépôt 2021-04-09
Date de la première publication 2021-10-21
Date d'octroi 2024-07-16
Propriétaire
  • Blue Earth Diagnostics Limited (Royaume‑Uni)
  • Siemens Medical Solutions USA, Inc. (USA)
Inventeur(s)
  • Bejot, Romain
  • Haka, Michael
  • Anzellotti, Atilio

Abrégé

18F or the chelating group contains a chelated radioactive metal, wherein the composition has a pH of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/mL ethanol; and 5-10 mg/mL sodium chloride.

Classes IPC  ?

  • A61K 51/04 - Composés organiques
  • A61K 47/02 - Composés inorganiques
  • A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
  • A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides

16.

PHARMACEUTICAL FORMULATIONS

      
Numéro de document 03179555
Statut En instance
Date de dépôt 2021-04-09
Date de disponibilité au public 2021-10-14
Propriétaire
  • SIEMENS MEDICAL SOLUTIONS USA, INC. (USA)
  • BLUE EARTH DIAGNOSTICS LTD (Royaume‑Uni)
Inventeur(s)
  • Bejot, Romain
  • Haka, Michael
  • Anzellotti, Atilio

Abrégé

The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a pH of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/mL ethanol; and 5-10 mg/mL sodium chloride.

Classes IPC  ?

17.

PHARMACEUTICAL FORMULATIONS

      
Numéro d'application GB2021050877
Numéro de publication 2021/205185
Statut Délivré - en vigueur
Date de dépôt 2021-04-09
Date de publication 2021-10-14
Propriétaire
  • BLUE EARTH DIAGNOSTICS LTD (Royaume‑Uni)
  • SIEMENS MEDICAL SOLUTIONS USA, INC. (USA)
Inventeur(s)
  • Bejot, Romain
  • Haka, Michael
  • Anzellotti, Atilio

Abrégé

The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a pH of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/mL ethanol; and 5-10 mg/mL sodium chloride.

Classes IPC  ?

18.

POSLUMA

      
Numéro d'application 1573560
Statut Enregistrée
Date de dépôt 2020-11-25
Date d'enregistrement 2020-11-25
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use. Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging. Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services.

19.

Imaging of metastatic or recurrent cancer

      
Numéro d'application 16907779
Numéro de brevet 10933147
Statut Délivré - en vigueur
Date de dépôt 2020-06-22
Date de la première publication 2020-10-08
Date d'octroi 2021-03-02
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s)
  • Miller, Matthew
  • Gauden, David
  • Schuster, David
  • Fanti, Stefano
  • Nanni, Cristina
  • Zanoni, Lucia
  • Willoch, Frode
  • Bogsrud, Trond
  • Bach-Gansmo, Tore
  • Musto, Alessandra

Abrégé

18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.

Classes IPC  ?

20.

Imaging of metastatic or recurrent cancer

      
Numéro d'application 16907863
Numéro de brevet 10967077
Statut Délivré - en vigueur
Date de dépôt 2020-06-22
Date de la première publication 2020-10-08
Date d'octroi 2021-04-06
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s)
  • Miller, Matthew
  • Gauden, David
  • Schuster, David
  • Fanti, Stefano
  • Nanni, Cristina
  • Zanoni, Lucia
  • Willoch, Frode
  • Bogsrud, Trond Velde
  • Bach-Gansmo, Tore
  • Musto, Alessandra

Abrégé

18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.

Classes IPC  ?

21.

POSLUMA

      
Numéro d'application 018286617
Statut Enregistrée
Date de dépôt 2020-08-07
Date d'enregistrement 2021-01-20
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use. Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging. Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services.

22.

POSLUMA

      
Numéro de série 90098473
Statut Enregistrée
Date de dépôt 2020-08-06
Date d'enregistrement 2021-09-14
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services

23.

Imaging of metastatic or recurrent cancer

      
Numéro d'application 16160227
Numéro de brevet 10716868
Statut Délivré - en vigueur
Date de dépôt 2018-10-15
Date de la première publication 2019-04-11
Date d'octroi 2020-07-21
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s)
  • Miller, Matthew
  • Gauden, David
  • Schuster, David
  • Fanti, Stefano
  • Nanni, Cristina
  • Zanoni, Lucia
  • Willoch, Frode
  • Bogsrud, Trond Velde
  • Bach-Gansmo, Tore
  • Musto, Alessandra

Abrégé

18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.

Classes IPC  ?

24.

BLUE EARTH

      
Numéro d'application 1429706
Statut Enregistrée
Date de dépôt 2018-07-31
Date d'enregistrement 2018-07-31
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; synthetic amino acids for use in PET imaging; reagents for use in PET imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging (non-medical). PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging (for medical use).

25.

Imaging of metastatic or recurrent cancer

      
Numéro d'application 14983746
Numéro de brevet 10124079
Statut Délivré - en vigueur
Date de dépôt 2015-12-30
Date de la première publication 2017-07-06
Date d'octroi 2018-11-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Inventeur(s)
  • Miller, Matthew
  • Gauden, David
  • Schuster, David
  • Fanti, Stefano
  • Nanni, Cristina
  • Zanoni, Lucia
  • Willoch, Frode
  • Bogsrud, Trond Velde
  • Bach-Gansmo, Tore
  • Musto, Alessandra

Abrégé

18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.

Classes IPC  ?

26.

AXUMIN

      
Numéro d'application 1321008
Statut Enregistrée
Date de dépôt 2016-10-13
Date d'enregistrement 2016-10-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; positron emission tomography (PET) imaging tracers; synthetic proteins and amino acids for use in pet imaging; reagents for use in PET imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging; contrast agents for use in molecular imaging. Diagnostic preparations for medical purposes; medical preparations for use in medical imaging; PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging; contrast agents for use in medical imaging; amino acids for use in medical imaging.

27.

AXUMIN

      
Numéro d'application 180452000
Statut Enregistrée
Date de dépôt 2016-10-13
Date d'enregistrement 2019-01-30
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

(1) Diagnostic chemical agents for scientific use namely, Positron Emission Tomography (PET) imaging tracers for diagnosing cancer; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for diagnosing cancer; reagents for use in Positron Emission Tomography (PET) imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging; contrast agents for use in molecular imaging; Diagnostic preparations for medical purposes namely, contrast agents for use in detecting cancer; medical preparations for use in medical imaging namely, contrast agents for use in detecting cancer; Positron Emission Tomography (PET) imaging tracers for injection into humans and animals for detecting cancer; reagents for medical purposes for detecting cancer; diagnostic scanning agents for medical use for detecting cancer; preparations for use in medical imaging namely, contrast agents for use in medical imaging; amino acids for use in medical imaging

28.

ZAMINAT

      
Numéro d'application 014275044
Statut Enregistrée
Date de dépôt 2015-06-19
Date d'enregistrement 2015-11-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; synthetic proteins and amino acids for use in PET imaging; reagents for use in PET imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging; contrast agents for use in molecular imaging. Diagnostic preparations for medical purposes; medical preparations for use in medical imaging; PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging; contrast agents for use in medical imaging; amino acids for use in medical imaging.

29.

AMINODEX

      
Numéro d'application 014269823
Statut Enregistrée
Date de dépôt 2015-06-19
Date d'enregistrement 2015-11-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; synthetic proteins and amino acids for use in PET imaging; reagents for use in PET imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging; contrast agents for use in molecular imaging. Diagnostic preparations for medical purposes; medical preparations for use in medical imaging; PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging; contrast agents for use in medical imaging; amino acids for use in medical imaging.

30.

AXUMIN

      
Numéro d'application 014275069
Statut Enregistrée
Date de dépôt 2015-06-19
Date d'enregistrement 2015-11-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; synthetic proteins and amino acids for use in PET imaging; reagents for use in PET imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging; contrast agents for use in molecular imaging. Diagnostic preparations for medical purposes; medical preparations for use in medical imaging; PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging; contrast agents for use in medical imaging; amino acids for use in medical imaging.

31.

AXUMIN

      
Numéro de série 86554828
Statut Enregistrée
Date de dépôt 2015-03-05
Date d'enregistrement 2016-06-28
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

[ Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in PET imaging for laboratory and research use; reagents for use in PET imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for non-medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use ] Diagnostic preparations for medical purposes; medical preparations in the nature of [ contrast agents, ] molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; PET imaging tracing chemicals for medical use; PET tracing chemicals and reagents prepared for [ ingestion or ] injection into humans [ and animals ] for medical use; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, [ contrast agents, ] molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; [ contrast agents for use in medical imaging; ] amino acids for use in medical imaging [ ; contrast agents for use in molecular imaging ]

32.

BLUE EARTH

      
Numéro de série 86538705
Statut Enregistrée
Date de dépôt 2015-02-18
Date d'enregistrement 2016-03-29
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

[ Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; ] diagnostic scanning agents for in-vivo use for medical research use [; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use ] Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for [ ingestion or ]injection into humans [ and animals ] for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, [ contrast agents, ] molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; [ contrast agents for use in medical imaging and molecular imaging; ] amino acids for use in medical imaging scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products [, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services ]; medical and pharmacological research services [ ; scientific consultancy in relation to the aforesaid services ] [ Medical services; ] Positron Emission Tomography (PET) medical imaging services; medical imaging services; medical services in the diagnosis of conditions in the body; providing medical consultancy in relation to the aforesaid services[ ; development of medical molecular imaging services ]

33.

BLUE EARTH

      
Numéro d'application 013195961
Statut Enregistrée
Date de dépôt 2014-08-22
Date d'enregistrement 2015-01-13
Propriétaire Blue Earth Diagnostics Limited (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; synthetic amino acids for use in PET imaging; reagents for use in PET imaging; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging. PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging. Scientific and technological services; research and design in relation to PET imaging; diagnostic research services; research in relation to molecular imaging; development of molecular imaging products and services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; consultancy in relation to the aforesaid services. Medical services; PET imaging services; medical imaging services; medical services in the diagnosis of conditions in the body; consultancy in relation to the aforesaid services.

34.

Process simplification for precursor compound

      
Numéro d'application 13994781
Numéro de brevet 09238596
Statut Délivré - en vigueur
Date de dépôt 2011-12-19
Date de la première publication 2013-10-17
Date d'octroi 2016-01-19
Propriétaire BLUE EARTH DIAGNOSTICS LIMITED (Royaume‑Uni)
Inventeur(s) Berg, Tom Christian

Abrégé

18F] FACBC) PET tracer.

Classes IPC  ?

  • C07C 227/20 - Préparation de composés contenant des groupes amino et carboxyle liés au même squelette carboné à partir de composés contenant déjà des groupes amino et carboxyle ou leurs dérivés par des réactions impliquant des groupes amino ou carboxyle, p. ex. hydrolyse d'esters ou d'amides, par formation d'halogénures, de sels ou d'esters par hydrolyse d'acides aminés N-acylés ou de leurs dérivés, p. ex. hydrolyse de carbamates
  • C07C 269/06 - Préparation de dérivés d'acide carbamique, c.-à-d. de composés contenant l'un des groupes l'atome d'azote ne faisant pas partie de groupes nitro ou nitroso par des réactions n'impliquant pas la formation de groupes carbamate
  • C07C 303/28 - Préparation d'esters ou d'amides d'acides sulfuriquesPréparation d'acides sulfoniques ou de leurs esters, halogénures, anhydrides ou amides d'esters d'acides sulfoniques par réaction de composés hydroxy avec des acides sulfoniques ou leurs dérivés
  • C07C 227/18 - Préparation de composés contenant des groupes amino et carboxyle liés au même squelette carboné à partir de composés contenant déjà des groupes amino et carboxyle ou leurs dérivés par des réactions impliquant des groupes amino ou carboxyle, p. ex. hydrolyse d'esters ou d'amides, par formation d'halogénures, de sels ou d'esters
  • C07B 59/00 - Introduction d'isotopes d'éléments dans les composés organiques